Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the veterinary biologics market right now?

In recent times, the size of the veterinary biologics market has experienced significant growth. The market is projected to expand from $12.67 billion in 2024 to $13.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors attributed to this growth in the past include animal disease outbreaks, regulatory support and standards, the need for food safety, trade globalization, and the economic value of livestock.

How fast Is the veterinary biologics market expected to grow, and what’s its future value?

In the coming years, the veterinary biologics market is projected to experience substantial growth, increasing to an estimated $18.38 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors attributed to this projected growth in the forecast period include the emergence of infectious diseases, changes in climate and disease patterns, the rise of precision livestock farming, the implementation of the ‘one health’ approach, and escalating trends in pet ownership. Noteworthy trends expected during this forecast period comprise of education and training initiatives, the use of environment-friendly and sustainable biologics, incorporation of digitised health records, expanded use of companion animal biologics, and the provision of personalised, goal-oriented therapies.

Get your veterinary biologics market report here!

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

What are the leading drivers of growth in the veterinary biologics market?

Animal illnesses are escalating which is expected to stimulate the expansion of the veterinary biologics industry. Animal diseases encompass medical problems that afflict different species of animals. The rise in animal diseases necessitates improved diagnosis and treatment, possible through the usage of veterinary biologics, which employ immunological methods to combat animal illnesses. For instance, the European Center for Disease Prevention and Control, a Sweden-based health agency of the European Union, reported in October 2022 that there were a total of 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds and 187 instances found in captive birds. Additionally, in July 2022, according to the World Health Organization, a specialised agency of the United Nations based in Switzerland, rabies claims the lives of 59,000 individuals per year in over 150 countries, with a staggering 95% of these cases witnessed in Africa and Asia. Consequently, the escalating instances of animal-related diseases are fuelling the progression of veterinary biologics.

What are the key segments defining the veterinary biologics market?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

Who are the key players steering the development of the veterinary biologics market?

Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

What emerging trends are influencing the growth of the veterinary biologics market?

Leading businesses in the veterinary biologics market are concentrating on the creation of new biologic products like vaccines, with the goal of improving animal health and preventing diseases. Vaccines, substances that trigger the immune system to identify and combat specific pathogens, assist in the prevention of infectious diseases by establishing acquired immunity. For instance, Merck Animal Health, a global animal health firm based in the US, launched a pioneering autogenous vaccine for avian metapneumovirus (aMPV) type B in August 2024. This vaccine was given the green light by the U.S. Department of Agriculture (USDA) for production and distribution. Created in association with Cambridge Technologies to tackle severe respiratory issues in poultry caused by aMPV type B, this vaccine aims to curb the significant financial losses that started in late 2023. The vaccine, manufactured at a cutting-edge Minnesota facility, employs an oil and water emulsion formula devised to diminish tissue reactions post-vaccination, thus filling a significant void in the market where there were no commercially licensed vaccines prior.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366

Which regions are most influential in expanding the veterinary biologics market?

North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Veterinary Anesthesia Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

Veterinary Disposables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-disposables-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: